Insights from 2023 European Multidisciplinary Congress on Urological Cancers

 

Insights from 2023 European Multidisciplinary Congress on Urological Cancers
A

EMUC 2023 Insights: "Durvalumab & RT Without Androgen Deprivation for Oligometastatic Prostate Cancer"

By Insights from 2023 European Multidisciplinary Congress on Urological Cancers FEATURING Alexander Guminski
By Insights from 2023 European Multidisciplinary Congress on Urological Cancers FEATURING Alexander Guminski
0 views
December 5, 2023
Comments 0
Login to view comments. Click here to Login
Videos
14:20
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

Management of Clinical Stage IIA/B Seminomatous Germ Cell Tumors

Feat. C. Oing
10:45
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "Risk-Adapted Strategy for Screening and Ea…

Feat. M. Roobol
10:27
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "How to Select My Patients for Conservative…

Feat. G. Niegisch
12:31
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "Nectin-4 Expression in Metastatic Urotheli…

Feat. N. Klümper
09:19
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "De-Escalating Strategies in mHSPC - Who, W…

Feat. B. Tombal
10:05
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "Durvalumab & RT Without Androgen Depri…

Feat. A. Guminski
23:07
Insights from 2023 European Multidisciplinary Congress on Urological Cancers

EMUC 2023 Insights: "Update on TALAPRO-2 and PROpel Prostate Ca…

Feat. F. Schlürmann